Correlation Between Ultragenyx and Krystal Biotech
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and Krystal Biotech, you can compare the effects of market volatilities on Ultragenyx and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and Krystal Biotech.
Diversification Opportunities for Ultragenyx and Krystal Biotech
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ultragenyx and Krystal is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Ultragenyx i.e., Ultragenyx and Krystal Biotech go up and down completely randomly.
Pair Corralation between Ultragenyx and Krystal Biotech
Given the investment horizon of 90 days Ultragenyx is expected to under-perform the Krystal Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Ultragenyx is 1.3 times less risky than Krystal Biotech. The stock trades about -0.06 of its potential returns per unit of risk. The Krystal Biotech is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 19,491 in Krystal Biotech on December 2, 2024 and sell it today you would lose (1,566) from holding Krystal Biotech or give up 8.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ultragenyx vs. Krystal Biotech
Performance |
Timeline |
Ultragenyx |
Krystal Biotech |
Ultragenyx and Krystal Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ultragenyx and Krystal Biotech
The main advantage of trading using opposite Ultragenyx and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Krystal Biotech vs. MeiraGTx Holdings PLC | Krystal Biotech vs. Apellis Pharmaceuticals | Krystal Biotech vs. Regenxbio | Krystal Biotech vs. Rhythm Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |